SPY760.14+0.04%QQQ689.96−0.06%BTC/USD74,665.82+1.31%DIA524.71+0.05%GLD365.18+0.00%TLT80.94+0.00%

Innoviva Inc

INVANASDAQ

Trade with Public

$18.86

-0.22-1.15%

Last update: Nov 11, 4:00 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Wed Nov 4th, after the market close

Innoviva (INVA) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Innoviva (INVA) stock.

Analyst Consensus — 5 Analysts

4Buy

1Sell

# Analysts5

Latest Upgrades and Downgrades for Innoviva Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Oppenheimer	Les Sulewski	PT Cut	Outperform	$35→$34
—	Oppenheimer	Les Sulewski	Assumes	Outperform	$35
—	Cantor Fitzgerald	Steve Seedhouse	PT Cut	Overweight	$36→$34
—	BTIG	Julian Harrison	Maintained	Buy	$42
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$46
—	BTIG	Julian Harrison	Maintained	Buy	$42
—	BTIG	Julian Harrison	PT Raise	Buy	$35→$42
—	BTIG	Julian Harrison	Maintained	Buy	$35
—	BTIG	Julian Harrison	Initiate	Buy	$35
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$45→$46
—	Cantor Fitzgerald	Steve Seedhouse	PT Raise	Overweight	$29→$31
—	Goldman Sachs	Asad Haider	Initiate	Sell	$17
—	Oppenheimer	Trevor Allred	Initiate	Outperform	$35
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$40→$45
—	HC Wainwright & Co.	Raghuram Selvaraju	Initiate	Buy	$40
—	Cantor Fitzgerald	Steve Seedhouse	Initiate	Overweight	$26
—	Scotiabank	Louise Chen	Initiate	Sector Outperform	$55
—	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
—	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
—	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—

Innoviva Inc

Innoviva (INVA) Stock Price Target 2026

Latest Upgrades and Downgrades for Innoviva Stock

Innoviva (INVA) Stock Price Target 2026

Latest Upgrades and Downgrades for Innoviva Stock

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on Innoviva, Lowers Price Target to $34

PRO
Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

PRO
Cantor Fitzgerald Maintains Overweight on Innoviva, Lowers Price Target to $34

PRO
HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

PRO
BTIG Reiterates Buy on Innoviva, Maintains $42 Price Target

PRO
BTIG Maintains Buy on Innoviva, Raises Price Target to $42

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on Innoviva, Lowers Price Target to $34

PRO
Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

PRO
Cantor Fitzgerald Maintains Overweight on Innoviva, Lowers Price Target to $34

PRO
HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

PRO
BTIG Reiterates Buy on Innoviva, Maintains $42 Price Target

PRO
BTIG Maintains Buy on Innoviva, Raises Price Target to $42

Innoviva Inc

Innoviva (INVA) Stock Price Target 2026

Latest Upgrades and Downgrades for Innoviva Stock

Innoviva (INVA) Stock Price Target 2026

Latest Upgrades and Downgrades for Innoviva Stock

Analyst Ratings News

PROOppenheimer Maintains Outperform on Innoviva, Lowers Price Target to $34

PROOppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

PROCantor Fitzgerald Maintains Overweight on Innoviva, Lowers Price Target to $34

PROHC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

PROBTIG Reiterates Buy on Innoviva, Maintains $42 Price Target

PROBTIG Maintains Buy on Innoviva, Raises Price Target to $42

People Also Watch

People Also Watch

Analyst Ratings News

PROOppenheimer Maintains Outperform on Innoviva, Lowers Price Target to $34

PROOppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

PROCantor Fitzgerald Maintains Overweight on Innoviva, Lowers Price Target to $34

PROHC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

PROBTIG Reiterates Buy on Innoviva, Maintains $42 Price Target

PROBTIG Maintains Buy on Innoviva, Raises Price Target to $42

PRO
Oppenheimer Maintains Outperform on Innoviva, Lowers Price Target to $34

PRO
Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

PRO
Cantor Fitzgerald Maintains Overweight on Innoviva, Lowers Price Target to $34

PRO
HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

PRO
BTIG Reiterates Buy on Innoviva, Maintains $42 Price Target

PRO
BTIG Maintains Buy on Innoviva, Raises Price Target to $42

PRO
Oppenheimer Maintains Outperform on Innoviva, Lowers Price Target to $34

PRO
Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

PRO
Cantor Fitzgerald Maintains Overweight on Innoviva, Lowers Price Target to $34

PRO
HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

PRO
BTIG Reiterates Buy on Innoviva, Maintains $42 Price Target

PRO
BTIG Maintains Buy on Innoviva, Raises Price Target to $42